• 800 343 7475ir@bio-techne.com bio-techne.com

    • Overview
    • News / Events
    • Company Information
    • Strategy
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    Navigation

      News / Events

    • Overview
    • News / Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Profile
      • Presentations
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Data
      • Overview
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • 10-K Filings
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents

    Press Releases

    • News / Events

    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    May 10, 2023

    BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA

    May 3, 2023

    BIO-TECHNE DECLARES DIVIDEND

    May 3, 2023

    BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS

    May 2, 2023

    BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE

    Apr 17, 2023

    BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION

    Apr 13, 2023

    BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE

    Apr 12, 2023

    BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS

    Apr 5, 2023

    BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA™ INSTRUMENTS NOW IN OPERATION

    Apr 3, 2023

    BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING

    Mar 15, 2023

    BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM

    RSS
    • 1...
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • ...49
    • Email Alerts
    • Contacts
    • RSS News Feed
    Bio-Techne

    614 McKinley Place NE
    Minneapolis, MN 55413
    USA

    TEL 612 379 2956
    Toll-free 800 343 7475
    FAX 612 656 4400

    Who We Are

    • About Bio-Techne
    • Bio-Techne Brands
    • Careers
    • Corporate & Social Responsibility
    • Terms and Conditions

    Investor Relations

    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance

    Stay Connected

    • Facebook Twitter LinkedIn YouTube Instagram
    • Contact Us

    Utility Footer Menu

    • Privacy and Cookie Policy
    • Site Map
    • © Copyright 2025 Bio-Techne. All Rights Reserved.